Half Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the AFT Pharmaceuticals FY 2023 Half Year Results Analyst Briefing. (Operator Instructions)
I would now like to hand the conference over to Dr. Hartley Atkinson, Managing Director. Please go ahead.
Good. Thank you very much, and thank you, everyone, for attending. So look, perhaps just to work for initially the investor presentation, to flip through that, I'll just talk to the pages. So there's Page #1 is the cover page. Page #2 is just a disclaimer. So please be aware of the details of that.
Now moving on to Page 3. What this is looking at is basically our growth from -- and we have had strong growth across our local Australasian business. Just a background, we have 150-plus products across 7 key therapeutic areas and they're distributed across 6,800 pharmacies. So there's about 5,800 in Australia and about 1,000 in New Zealand. Asia, we -- another region, we have a broad range of products sold in the Asia
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
